4.8 Article

Genomic Evolution of Breast Cancer Metastasis and Relapse

期刊

CANCER CELL
卷 32, 期 2, 页码 169-+

出版社

CELL PRESS
DOI: 10.1016/j.ccell.2017.07.005

关键词

-

资金

  1. Wellcome Trust [FC001202]
  2. Bergen Research Foundation
  3. Norwegian Cancer Society
  4. Norwegian Research Council
  5. Belgian Cancer Plan-Ministry of Health
  6. Breast Cancer Research Foundation
  7. Brussels Region
  8. University of Cambridge
  9. Cancer Research UK
  10. Hutchison Whampoa Limited
  11. Wellcome Trust research fellowship
  12. European Hematology Association
  13. Cancer Genomics Netherlands (CGC.nl) through Netherlands Organisation for Scientific Research (NWO)
  14. Cancer Research UK Program Grant [C14303/A17197]
  15. U.S. Department of Energy National Nuclear Security Administration [DE-AC52-06NA25396]
  16. National Nuclear Security Administration of the United States Department of Energy
  17. Francis Crick Institute, from Cancer Research UK [FC001202]
  18. UK Medical Research Council [FC001202]
  19. Cancer Research UK [21777, 19556] Funding Source: researchfish
  20. Cancer Research UK
  21. Versus Arthritis [20406] Funding Source: researchfish
  22. The Francis Crick Institute [10202] Funding Source: researchfish

向作者/读者索取更多资源

Patterns of genomic evolution between primary and metastatic breast cancer have not been studied in large numbers, despite patients with metastatic breast cancer having dismal survival. We sequenced whole genomes or a panel of 365 genes on 299 samples from 170 patients with locally relapsed or metastatic breast cancer. Several lines of analysis indicate that clones seeding metastasis or relapse disseminate late from primary tumors, but continue to acquire mutations, mostly accessing the same mutational processes active in the primary tumor. Most distant metastases acquired driver mutations not seen in the primary tumor, drawing from a wider repertoire of cancer genes than early drivers. These include a number of clinically actionable alterations and mutations inactivating SWI-SNF and JAK2-STAT3 pathways.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据